Video categories
Wessex NHS Genomic Medicine Centre patient Ilona and her clinicians tells us about how sequencing led to a diagnosis for her critical illness and saved her life.
Bill Gillespie, the CEO at Wessex AHSN, explains the four key stages to support the adoption and spread of innovations, at scale, in the NHS.
How we connect academics, NHS, industry and others to bring fresh energy to old problems, inspired thinking to new ones and to spread innovation and best practice.
At Wesex AHSN we improve people's health, achieve excellence in healthcare and boost innovation and growth in our region's life sciences and healthcare sector.
The 100,000 Genomes Project in Wessex: Progress & integration into care
Held on 03 October 2018 in Southampton, the event celebrated the transition from the national 100,000 Genomes Project to the new NHS Genomic Medicine Service.
Watch the highlights from keynote speaker Professor Dame Sue Hill (Chief Scientific Officer for England) and regional contributors, who showcased national plans and local achievements.
The 100,000 Genomes Project in Wessex: Progress & integration into care
Held on 03 October 2018 in Southampton, the event celebrated the transition from the national 100,000 Genomes Project to the new NHS Genomic Medicine Service.
Keynote speaker Professor Dame Sue Hill (Chief Scientific Officer for England) presents plans for the new NHS Genomic Medicine Service.
The 100,000 Genomes Project in Wessex: Progress & integration into care
Held on 03 October 2018 in Southampton, the event celebrated the transition from the national 100,000 Genomes Project to the new NHS Genomic Medicine Service.
Wessex GMC's Clinical Co-Director, Professor Tony Williams, presents an overview of the 100,000 Genomes Project in the Wessex region.
The 100,000 Genomes Project in Wessex: Progress & integration into care
Held on 03 October 2018 in Southampton, the event celebrated the transition from the national 100,000 Genomes Project to the new NHS Genomic Medicine Service.
Professor Karen Temple, Clinical Co-Director for Wessex GMC, presents the impact on rare disease of the 100,000 Genomes Project and the future direction.